“We want to accelerate growth”
Solvay Pharmaceuticals has a strategy of growth through new therapies. We focus on selected therapeutic fields: Cardiology, Gastroenterology, Women’s and Men’s health, Mental health and Influenza vaccines.
We strive to a worldwide presence with above-market growth in North-America, Central and Eastern Europe, the Middle East and Asia.
We create new products and growth from inside the organization through a high level of investment in active discovery and development programs. Our R&D pipeline now counts over 30 promising compounds.
Our patients, our employees and our shareholders are our most important stakeholders. Our major challenge is to achieve a balance in the focus on their interests, following the company’s values.